Taligen Therapeutics' Series B Round

Taligen Therapeutics raised a round of funding on January 21, 2008.

Taligen Therapeutics is a development-stage biotechnology company. In January 2011, Taligen Therapeutics was acquired by Alexion Pharmaceuticals. The valuation of Taligen Therapeutics was $111 millio…

Articles about Taligen Therapeutics' Series B Round: